Anu R. Thummala
Oncology
7445 Peak Dr
Las Vegas, NV 89128
Las Vegas, NV 89128
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 21, 2021
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1, TRIO-18).
Journal: Breast cancer research and treatment
Published: March 31, 2020
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial.
Journal: The Lancet. Oncology
Published: July 29, 2019
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
Journal: The Lancet. Oncology
Published: December 20, 2014
Showing 1-4 of 4
Last Updated: 09/26/2026